Sol Derma Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 5.00 M
as on 24-10-2024
- Company Age 16 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 6.00 Cr
as on 24-10-2024
- Satisfied Charges ₹ 2.83 Cr
as on 24-10-2024
- Revenue 75.14%
(FY 2023)
- Profit 121.14%
(FY 2023)
- Ebitda 76.27%
(FY 2023)
- Net Worth 58.59%
(FY 2023)
- Total Assets 69.22%
(FY 2023)
About Sol Derma Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹6.00 Cr. The company has closed loans amounting to ₹2.83 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ronakkumar Patel, Mehulkumar Gandhi, Amrish Gandhi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24239GJ2008PTC055073
- Company No.
055073
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Sep 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sol Derma Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ronakkumar Patel  | Managing Director | 18-Sep-2008 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Mehulkumar Gandhi | Additional Director | 27-Mar-2015 | Current |
| Amrish Gandhi | Additional Director | 04-Apr-2015 | Current |
| Ramkrishna Patel | Director | 27-Jun-2018 | Current |
| Pravinbhai Patel | Director | 10-Aug-2016 | Current |
Financial Performance of Sol Derma Pharmaceuticals.
Sol Derma Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 75.14% increase. The company also saw a substantial improvement in profitability, with a 121.14% increase in profit. The company's net worth Soared by an impressive increase of 58.59%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sol Derma Pharmaceuticals?
In 2023, Sol Derma Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sana Diamond Engi-Mech Limited Liability PartnershipActive 8 years 4 monthsRamkrishna Patel is a mutual person
Arovea Formulations Private LimitedActive 3 years 6 monthsRonakkumar Patel and Pravinbhai Patel are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 02 Mar 2022 | ₹6.00 Cr | Open |
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 03 Apr 2021 | ₹2.00 Cr | Satisfied |
The Ratnakar Bank Limited Creation Date: 29 Mar 2013 | ₹8.30 M | Satisfied |
How Many Employees Work at Sol Derma Pharmaceuticals?
Sol Derma Pharmaceuticals has a workforce of 319 employees as of Apr 10, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sol Derma Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sol Derma Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
